{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:51:33Z","timestamp":1790484693108,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ejogrb.2017.06.005","type":"journal-article","created":{"date-parts":[[2017,6,4]],"date-time":"2017-06-04T11:31:41Z","timestamp":1496575901000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Do tumor-infiltrating lymphocytes really indicate favorable prognosis in epithelial ovarian cancer?"],"prefix":"10.1016","volume":"215","author":[{"given":"Nuri","family":"Yildirim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Akman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamuran","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuran","family":"Alan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Zekioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Cosan","family":"Terek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necmettin","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydin","family":"Ozsaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2017.06.005_bib0005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","article-title":"Estimates of the cancer incidence and mortality in Europe in 2006","volume":"18","author":"Ferlay","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0010","first-page":"71","article-title":"Cancer statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0015","first-page":"195","volume":"15","author":"Pfisterer","year":"2005","journal-title":"The role of surgery in recurrent ovarian cancer Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0020","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/01.AOG.0000220516.34053.48","article-title":"Diagnosis and management of epithelial ovarian cancer","volume":"107","author":"Bhoola","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000341366","article-title":"Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel\/platinum chemotherapy the impact of novel agents","volume":"84","author":"Bamias","year":"2013","journal-title":"Oncology"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ygyno.2007.10.016","article-title":"Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma","volume":"108","author":"Tomsov\u00e1","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0050","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med."},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0055","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00262-008-0583-5","article-title":"Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer","volume":"58","author":"Leffers","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0065","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/cmi.2015.57","article-title":"Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment","volume":"12","author":"Zhang","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2011.09.039","article-title":"Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis","volume":"124","author":"Hwang","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0075","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1073\/pnas.0611533104","article-title":"Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer","volume":"104","author":"Hamanishi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0080","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1007\/s13277-015-3206-8","article-title":"Increased number of forkhead box P3+ tumor-infiltrating lymphocytes correlates with high preoperative albumin level and better survival in patients with stage II or III colorectal cancer","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0085","doi-asserted-by":"crossref","first-page":"e985930","DOI":"10.4161\/2162402X.2014.985930","article-title":"Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC)","volume":"4","author":"Adams","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0090","first-page":"1847","article-title":"Regulatory T cells and their prognostic value in hepatopancreatobiliary tumours","volume":"61","author":"Ozgur","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0095","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/annonc\/mdi112","article-title":"Tumour-infiltrating gamma\/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma","volume":"16","author":"Raspollini","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0100","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clim.2011.08.013","article-title":"The comprehensive assessment of local immune status of ovarian cancer by the clustering of multiple immune factors","volume":"141","author":"Hamanishi","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0105","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/sj.bjc.6605274","article-title":"Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes","volume":"101","author":"Stumpf","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0110","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0115","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1158\/0008-5472.CAN-12-0579","article-title":"CXCR3C T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity","volume":"72","author":"Redjimi","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0120","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/15384047.2015.1040960","article-title":"Tumor infiltrating lymphocytes in ovarian cancer","volume":"16","author":"Santoiemma","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0125","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","article-title":"Natural regulatory T cells: mechanisms of suppression","volume":"13","author":"Miyara","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0130","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1007\/s13277-015-4237-x","article-title":"Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8(+) T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression","volume":"37","author":"Bu","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0135","doi-asserted-by":"crossref","first-page":"e6412","DOI":"10.1371\/journal.pone.0006412","article-title":"Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20 FoxP3 and TIA-1 as positive prognostic factors","volume":"4","author":"Milne","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0140","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1158\/1078-0432.CCR-07-0842","article-title":"CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer","volume":"13","author":"Kiniwa","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1479-5876-9-189","article-title":"Distribution, characterization, and induction of CD8+ regulatory T cells and IL-17- producing CD8+ T cells in nasopharyngeal carcinoma","volume":"9","author":"Li","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.ejogrb.2017.06.005_bib0150","doi-asserted-by":"crossref","first-page":"15621","DOI":"10.18632\/oncotarget.14919","article-title":"The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517302798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517302798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:40:57Z","timestamp":1759556457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211517302798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":30,"alternative-id":["S0301211517302798"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.06.005","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do tumor-infiltrating lymphocytes really indicate favorable prognosis in epithelial ovarian cancer?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}